Gene Therapy May Hold Key to HIV Cure, If Government Allows It
Using patients’ genetic material to help attack their particular version of HIV.
New Single-Tablet Regimen: FDA Approves Triumeq
ViiV Healthcare’s single-tablet regimen Triumeq won Food and Drug Administration approval on August 22, 2014. Triumeq is the first FDA-approved single-tablet regimen (STR) that does not contain tenofovir (Viread), a widely used antiretroviral drug linked with bone and kidney problems in some susceptible HIV-positive individuals.
STUDY: HIV Drug Resistance Linked to Long Term Use of Certain Antiretrovirals
A meta-analysis of HIV patients in China shows strong relationship between didanosine-based treatments and increase in drug resistance.